Technology News and Research

RSS

Anthera Pharmaceuticals closes financing transaction

Anthera Pharmaceuticals, Inc., today announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder.

23 Sep 2010

pSivida reports $8.8 million consolidated net income for 2010 fiscal year

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back of the eye diseases, including the product candidate Iluvien for the treatment of Diabetic Macular Edema, today announced financial results for its fourth quarter and fiscal year ended June 30, 2010.

23 Sep 2010

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood.

22 Sep 2010

GATC Biotech to purchase PacBio real-time sequencing technology

GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.

22 Sep 2010

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.

22 Sep 2010

Nationwide Health Information Network tool to convey public health information

One hundred and sixty-six years after Samuel Morse used dots and dashes to telegraph "What hath God wrought?" opening up a whole new world of communication, Indiana has become the first state in the nation to use a potentially equally revolutionary tool, the Nationwide Health Information Network, to convey public health information to the U.S. Centers for Disease Control and Prevention.

22 Sep 2010

Scientists develop new therapy for treatment of skin, lung cancer

Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.

22 Sep 2010

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.

22 Sep 2010

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Viking Systems, Inc. announced today its Next Generation 3DHD Visualization System for use in minimally invasive surgery will be prominently featured at Sony's media event to be held September 23, 2010 at Sony's offices in New York, NY. Jed Kennedy, Viking Systems President and CEO and Gerald Andriole, M.D., Medical Advisor to Viking Systems will address the media and explain the features and benefits of the system.

22 Sep 2010

Health insurer Highmark standardizes on Informatica Platform for enterprise-wide data integration

Informatica Corporation, the world's number one independent provider of data integration software, today announced that Highmark Inc., one of the largest health insurers in the United States, has standardized on the Informatica Platform for enterprise-wide data integration.

22 Sep 2010

Newborn Coalition praises SACHDNC's Critical Congenital Heart Disease universal screening recommendation

In a historic vote on September 17, 2010, the Secretary's Advisory Committee for Heritable Disorders in Newborns and Children (SACHDNC) unanimously agreed to recommend the addition of screening for Critical Cyanotic Congenital Heart Disease to the core panel for universal screening of all newborns in the United States.

22 Sep 2010

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

An eminent international panel of judges has selected Eli Lilly and Company to receive a World Business and Development Award for demonstrating what can be achieved through successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB).

22 Sep 2010

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.

22 Sep 2010

ART closes new $8.5 million venture financing round

Arterial Remodeling Technologies ("ART") announced today that it has closed on a new venture financing round of $8.5 million from existing investors Matignon Technologies and Amundi Private Equity Funds, along with new investor InnoBio Fund managed by CDC Entreprises. Total investment in the Company is now $17 million.

22 Sep 2010

Delphi Genetics licences StabyExpress technology for production of protein vaccines to GSK

Delphi Genetics SA has announced today the signature of a licensing agreement with GlaxoSmithKline for the use of the patented StabyExpress technology for the production of protein vaccines for human use.

22 Sep 2010

Shrink Nanotechnologies leases laboratory space inside TechPortal

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has leased laboratory space (the "NanoShrink Lab") inside the TechPortal, an innovative and brand new technology facilitator center for commercial bioscience research companies which are in most cases based on University of California, Irvine research.

22 Sep 2010

PRC offers 'IVF Second Chances' program to fertility patients

Fertility patients who don't get pregnant on their first try at in vitro fertilization (IVF) will get a second chance for free at Pacific Reproductive Center (PRC), under a new program the fertility clinic announced today.

22 Sep 2010

Agilent, ISB and ETH Zurich enter second phase of mapping complete human proteome

Ninth Annual World Conference of the Human Proteome Organization -- Agilent Technologies Inc. (NYSE:A) today announced that its collaboration with the Institute for Systems Biology (ISB) and the Swiss Federal Institute of Technology (ETH Zurich) for the mapping of the complete human proteome by mass spectrometry is entering its second phase.

22 Sep 2010

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.

22 Sep 2010

U.S. community health centers receive $500,000 grant to increase access to quality healthcare

The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.

22 Sep 2010

Technology News and Research

Anthera Pharmaceuticals closes financing transaction

pSivida reports $8.8 million consolidated net income for 2010 fiscal year

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

GATC Biotech to purchase PacBio real-time sequencing technology

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Nationwide Health Information Network tool to convey public health information

Scientists develop new therapy for treatment of skin, lung cancer

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Health insurer Highmark standardizes on Informatica Platform for enterprise-wide data integration

Newborn Coalition praises SACHDNC's Critical Congenital Heart Disease universal screening recommendation

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

ART closes new $8.5 million venture financing round

Delphi Genetics licences StabyExpress technology for production of protein vaccines to GSK

Shrink Nanotechnologies leases laboratory space inside TechPortal

PRC offers 'IVF Second Chances' program to fertility patients

Agilent, ISB and ETH Zurich enter second phase of mapping complete human proteome

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

U.S. community health centers receive $500,000 grant to increase access to quality healthcare

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News